Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Javier de Diego-Adeliño"'
Autor:
Muriel Vicent-Gil, Joan Trujols, Maria Serra-Blasco, Guillem Navarra-Ventura, Dolors Puigdemont, Carlo Alemany, Sara Crivillés, Javier de Diego-Adeliño, Narcís Cardoner, Maria J. Portella
Publikováno v:
European Psychiatry, Vol 66 (2023)
Abstract Background The purpose of this exploratory study is to examine the role of sociodemographic, clinical, and cognitive – both objective and subjective – factors in overall and in specific domains of psychosocial functioning, in patients w
Externí odkaz:
https://doaj.org/article/18249fc02c144f2e9d1db7a6f01be9f5
Autor:
Javier R. Caso, Karina S. MacDowell, Ana González-Pinto, Saínza García, Javier de Diego-Adeliño, Mar Carceller-Sindreu, Fernando Sarramea, Javier Caballero-Villarraso, Patricia Gracia-García, Concepción De la Cámara, Luis Agüera, María L. Gómez-Lus, Claudio Alba, Juan M. Rodríguez, Juan C. Leza
Publikováno v:
Translational Psychiatry, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Although alterations in the gut microbiota have been linked to the pathophysiology of major depressive disorder (MDD), including through effects on the immune response, our understanding is deficient about the straight connection patterns am
Externí odkaz:
https://doaj.org/article/923dbf1f394842af9740797129206d51
Autor:
Muriel Vicent-Gil, Beatriz Raventós, Eduardo D. Marín-Martínez, Sara González-Simarro, Anabel Martínez-Arán, Caterina del Mar Bonnin, Joan Trujols, Josefina Pérez-Blanco, Javier de Diego-Adeliño, Dolors Puigdemont, Maria Serra-Blasco, Narcís Cardoner, Maria J. Portella
Publikováno v:
BMC Psychiatry, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Given the limitation of pharmacological treatments to treat cognitive symptoms in patients with Major Depressive Disorder (MDD), cognitive remediation programs has been proposed as a possible procognitive intervention but findings
Externí odkaz:
https://doaj.org/article/75541a74e9bb40dc8d292240a222a5a4
Autor:
Muriel Vicent-Gil, Sara González-Simarro, Beatriz Raventós, Javier Vera, Eduardo D. Marín Martínez, Carlota Sabaté-Cao, Josefina Pérez-Blanco, Dolors Puigdemont, Javier de Diego-Adeliño, Carlo Alemany, Maria Serra-Blasco, Narcís Cardoner, Maria J. Portella
Publikováno v:
Journal of Affective Disorders. 310:189-197
Despite achieving clinical remission, patients with depression encounter difficulties to return to their premorbid psychosocial functioning. Cognitive dysfunction has been proposed to be a primary mediator of functional impairment. Therefore, the new
Autor:
Víctor Pérez, Ariana Salavert, Jordi Espadaler, Miquel Tuson, Jerónimo Saiz-Ruiz, Cristina Sáez-Navarro, Julio Bobes, Enrique Baca-García, Eduard Vieta, José M. Olivares, Roberto Rodriguez-Jimenez, José M. Villagrán, Josep Gascón, Josep Cañete-Crespillo, Montse Solé, Pilar A. Saiz, Ángela Ibáñez, Javier de Diego-Adeliño, AB-GEN Collaborative Group, José M. Menchón
Publikováno v:
BMC Psychiatry, Vol 17, Iss 1, Pp 1-13 (2017)
Abstract Background A 12-week, double-blind, parallel, multi-center randomized controlled trial in 316 adult patients with major depressive disorder (MDD) was conducted to evaluate the effectiveness of pharmacogenetic (PGx) testing for drug therapy g
Externí odkaz:
https://doaj.org/article/d5844f200b4f4f299135845fb3c486c5
Autor:
Azucena Justicia, Matilde Elices, Ana Isabel Cebria, Diego J. Palao, Jesús Gorosabel, Dolors Puigdemont, Javier de Diego-Adeliño, Andrea Gabilondo, Alvaro Iruin, Ulrich Hegerl, Víctor Pérez
Publikováno v:
BMC Psychiatry, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background During the last decade online interventions have emerged as a promising approach for patients with mild/moderate depressive symptoms, reaching at large populations and representing cost-effective alternatives. The main objective o
Externí odkaz:
https://doaj.org/article/a75f64712e1e459f815da31353e84eae
Autor:
Javier De Diego-Adeliño, José Manuel Crespo, Fernando Mora, Adrián Neyra, Pedro Iborra, Luis Gutiérrez-Rojas, Selman F. Salonia
Publikováno v:
Expert Opinion on Drug Safety. 21:673-690
Vortioxetine is a multimodal-acting antidepressant that provides improvements on cognitive function aside from antidepressants and anxiolytic effects. Vortioxetine has been found to be one of the most effective and best tolerated options for major de
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joan Trujols, Javier de Diego-Adeliño, Maria J. Portella, Carlo Alemany, Ioseba Iraurgi, Juan V. Luciano, Dolors Puigdemont, Victor L. Perez, Albert Feliu-Soler
Publikováno v:
International Journal of Environmental Research and Public Health
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
International Journal of Environmental Research and Public Health, Vol 18, Iss 10964, p 10964 (2021)
Volume 18
Issue 20
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
International Journal of Environmental Research and Public Health, Vol 18, Iss 10964, p 10964 (2021)
Volume 18
Issue 20
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Despite the considerable amount of research evidence on the significant role of subjective happiness on mental health, there is no psychometric study of the Subjective Happiness Scale (SHS) in psychiatric samples. This study was aimed at exploring th
Autor:
Metodi Draganov, Javier de Diego-Adeliño, Míriam Jubero, Juliana Salazar, Maria J. Portella, Maria Arranz, Cristina Gallego-Fabrega, Mar Carceller-Sindreu
Publikováno v:
EUROPEAN PSYCHIATRY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background:Although pharmacogenetics for major depressive disorder (MDD) is gaining momentum, the role of genetics in differences in response to antidepressant treatment is controversial, as they depend on multifactorial and polygenic phenotypes. Pre